AQUINOX PHARMACEUTICALS INC - COM (AQXP)

CUSIP: 03842B101

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
23,041,455
Share change
+1,143,245
Total reported value
$384,298,000
Put/Call ratio
92%
Price per share
$16.69
Number of holders
39
Value change
+$19,134,249
Number of buys
15
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q1 2017

As of 31 Mar 2017, AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by 39 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,041,455 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Boxer Capital, LLC, VANGUARD GROUP INC, Ghost Tree Capital, LLC, and EVENTIDE ASSET MANAGEMENT, LLC. This page lists 39 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.